Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.
about
Endoglin expression in metastatic breast cancer cells enhances their invasive phenotypeAnalysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing propertiesHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsCannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effectTransmembrane chemokines act as receptors in a novel mechanism termed inverse signalingThe chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.Akt1 governs breast cancer progression in vivo.Two-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sitesUp-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiationEffects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosisTranscript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.Comparative transcriptomics reveals similarities and differences between astrocytoma grades.CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.Expression analysis and clinical significance of CXCL16/CXCR6 in patients with bladder cancer.The perioperative time course and clinical significance of the chemokine CXCL16 in patients undergoing cardiac surgeryRadiation-induced CXCL16 release by breast cancer cells attracts effector T cells.CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoproteinApplication of immunoaffinity capillary electrophoresis to the measurements of secreted cytokines by cultured astrocytes.Chemokines in CNS injury and repair.The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.Immunotherapy and radiation in glioblastoma.Systematic substrate identification indicates a central role for the metalloprotease ADAM10 in axon targeting and synapse functionBiological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging.CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-β1.Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells.Cannabinoid receptors in human astroglial tumors.The chemokine CXCL16 modulates neurotransmitter release in hippocampal CA1 area."Inverse signaling" of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells.Neuroinflammation in advanced canine glaucoma.The gender-specific association of CXCL16 A181V gene polymorphism with susceptibility to multiple sclerosis, and its effects on PBMC mRNA and plasma soluble CXCL16 levels: preliminary findings.IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke
P2860
Q24307831-8373DA76-0085-49B6-81F6-0AD2BF56EF8DQ27491282-CAC85E1B-11AE-4B84-8E1C-B9A8A46B78E5Q28392199-09767B97-B522-4A89-95D8-4B2E4D6F6595Q28534561-19D938C4-4ADB-4381-BEA6-A01266BAFC44Q28601403-5BA6A6D8-475D-44DD-8877-9B98B01AB045Q30438926-1CF31AB2-11C9-4463-BDBD-3513D0BBBD34Q30479413-928E796A-83D0-4F3B-84DE-529AAA04A9B8Q30492842-EC1057BA-B5E5-4B7C-BFB1-41FA3E158238Q33802647-CC683B07-BCAA-4133-8901-EC07AE1719D2Q33829364-C16E4B47-2DE2-4B00-941A-F9EB36EA9363Q33909085-13EEAF31-FFDA-455D-8B65-773EFCAE4046Q34555203-3F330E0F-E646-46A2-B485-852AD0073DC4Q35139265-92A8B45F-2C78-4845-AD31-7BD23A009FEFQ35682561-F6404580-4EB2-432E-AEA5-6921B81B734AQ35833218-534FCB6D-CD4F-46D2-A8C5-07586BEC0A78Q35870174-5FF7F47A-4561-4C04-B4D5-A38EC1F96566Q35987292-7AFA8D41-6D48-4AD3-BA08-5D65C94995C1Q36475434-4223DF3E-8AD8-4441-A8F7-77118A5B0B1DQ36476906-F042AEA5-086B-43F2-86DB-3BE8383D2D06Q36983211-C3BA070C-8C09-4B65-84A0-2A2D72F589DEQ37197326-488AE298-C80E-422C-ABEA-34206D3631AEQ37372527-50B7C26E-74B1-4FD0-B9BD-CF5F270C7B0FQ38018862-52EAE380-6C1E-4043-A9C4-5F23B5AB4C94Q38697515-34C52DFC-6717-4938-AF90-AF8CD8BD31DCQ38752191-2D596B2E-BB28-409E-A8E8-565068B3657EQ38911059-BC91EC01-47A8-43F2-B8C4-542BA97E783BQ39588306-38A246A0-6FE5-439E-A891-10964362B252Q39698815-3819F162-1B4B-49B0-9EC2-CC5C1AC58B8FQ39741940-A6D5B999-49CC-48EC-8D45-C20DF9BDBAF6Q40246451-D192857C-CDD6-4714-86FF-59F108FCF48CQ41380654-F1932DFD-0353-423B-ACAF-5198B8BC6EC9Q41592743-E2F0762B-14FD-43CB-97FF-9F2E4641BEB0Q42395481-41CFC391-D4B8-4E06-8CDE-D674E499F484Q51138727-061D7D14-3B8D-4F66-98C0-9795D987E377Q59125563-FBA9F843-1021-4F07-A747-85D0AA7581F3
P2860
Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Enhanced expression and sheddi ...... e astrocytes and glioma cells.
@en
type
label
Enhanced expression and sheddi ...... e astrocytes and glioma cells.
@en
prefLabel
Enhanced expression and sheddi ...... e astrocytes and glioma cells.
@en
P2093
P2860
P50
P1476
Enhanced expression and sheddi ...... ve astrocytes and glioma cells
@en
P2093
Cathrin Schnack
Christian Hundhausen
Janka Held-Feindt
Karina Reiss
Neil Brodway
P2860
P304
P356
10.1111/J.1471-4159.2005.03123.X
P407
P577
2005-06-01T00:00:00Z